Skip to main content

Cogenics Using 454 Sequencing in Crop Collaboration

NEW YORK (GenomeWeb News) – Cogenics and Roche subsidiary 454 Life Sciences will collaborate to develop SNPs for the plant breeder Limagrain that could be used to engineer better crops including wheat, Cogenics’ parent company Clinical Data said today.
 
Under the agreement, Cogenics will develop a genome complexity reduction assay to select gene-rich portions of a crop genome across multiple variants of the species.
 
Clinical Data said Cogenics will work with 454 to sequence around 2Gb of the wheat genome using the GS-FLX sequencer. The sequencing is the first step in a two-stage process, through which the companies will identify molecular markers linked with desirable characteristics.
 
Jean-Pierre Martinant, who heads a genotyping facility of Limagrain Verneuil Holding in France, said the collaboration with Cogenics and 454 “will significantly enhance our ability to accelerate the large scale genotyping campaigns required to meet the goals of this project.”
 
Financial terms of the agreement were not released.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.